Calluna Pharma
Creating pioneering treatments to combat chronic inflammation and fibrosis from their root causes.
Launch date
Employees
Market cap
-
Enterprise valuation
€300—450m (Dealroom.co estimates Jan 2024.)
Company register number 932255189
Oslo Norway (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €75.0m | Series A | |
| Total Funding | €75.0m | ||